| scientific journal | Q5633421 |
| P6981 | ACNP journal ID | 3166239 |
| P8375 | Crossref journal ID | 238806 |
| P8903 | HAL journal ID | 126884 |
| P236 | ISSN | 2197-0378 |
| P7363 | ISSN-L | 2197-0378 |
| P1055 | NLM Unique ID | 101659261 |
| P856 | official website | http://link.springer.com/journal/40629 |
| P10283 | OpenAlex ID | S2764413502 |
| P3181 | OpenCitations bibliographic resource ID | 1909749 |
| P8104 | Paperity journal ID | 2375 |
| P7662 | Scilit journal ID | 516657 |
| P1156 | Scopus source ID | 21100854121 |
| P5983 | Springer journal ID | 40629 |
| P495 | country of origin | Germany | Q183 |
| P8875 | indexed in bibliographic review | Scopus | Q371467 |
| P407 | language of work or name | English | Q1860 |
| P123 | publisher | Springer Science+Business Media | Q176916 |
| Springer Medizin | Q29458659 | ||
| P1476 | title | Allergo journal international |
| Q36688498 | 13-year overview of serious adverse drug reactions following subcutaneous specific immunotherapy with a chemically modified allergen preparation |
| Q59528318 | Abridged version of the AWMF guideline for the medical clinical diagnostics of indoor mould exposure: S2K Guideline of the German Society of Hygiene, Environmental Medicine and Preventive Medicine (GHUP) in collaboration with the German Association o |
| Q94378881 | Abstracts of the 27th Spring Symposium of the German Society of Allergy and Clinical Immunology, Mainz, March 12th -13th, 2015: Presentations |
| Q35776991 | Abstracts, 9th German Allergy Congress, Wiesbaden, 2-4 October 2014 |
| Q42024011 | Acid suppression therapy and allergic reactions |
| Q35776972 | Acupuncture in allergic rhinitis: A Mini-Review |
| Q129105940 | Air pollutants and primary allergy prevention |
| Q39012647 | Allergen and allergy risk assessment, allergen management, and gaps in the European Food Information Regulation (FIR): Are allergic consumers adequately protected by current statutory food safety and labelling regulations? |
| Q129027768 | Allergen immunotherapy for oral allergy syndrome: what is the evidence for efficacy? |
| Q37639370 | Allergens and molecular diagnostics of shellfish allergy: Part 22 of the Series Molecular Allergology |
| Q129907388 | Allergic heparin hypersensitivity – recommendations for diagnostic work up and patient management |
| Q129250199 | Allergies and vaccination: a myth demystified |
| Q38940758 | Allergy and school: nothing to be sneezed at!: A primary school project in Bielefeld, Germany, on epidemiology and health promotion in allergic diseases |
| Q125471148 | Allergy to the cat—from diagnosis to management |
| Q31102220 | Ambrosia artemisiifolia (ragweed) in Germany - current presence, allergological relevance and containment procedures |
| Q100992734 | Anti-inflammatory substances from onions could be an option for treatment of COVID-19-a hypothesis |
| Q127216403 | Ash pollen allergy and aerobiology |
| Q40223285 | Ash pollen allergy: reliable detection of sensitization on the basis of IgE to Ole e 1. |
| Q125408474 | Assessing the relevance of allergenic pollen in indoor environments—current knowledge base and research needs |
| Q127791940 | Atopic eczema score of emotional consequences—a questionnaire to assess emotional consequences of atopic eczema |
| Q40292349 | Author guidelines: Allergo Journal International |
| Q42408278 | Author guidelines: Allergo Journal International |
| Q35777063 | Authorised allergen products for intracutaneous testing may no longer be available in Germany: Allergy textbooks have to be re-written |
| Q38539747 | Autoallergy in atopic dermatitis |
| Q125472586 | Avoidance measures for mite allergy—an update |
| Q37620072 | A novel experimental technology for testing efficacy of air purifiers on pollen reduction |
| Q35776996 | Benefits and limitations of molecular diagnostics in peanut allergy: Part 14 of the series Molecular Allergology |
| Q56992612 | Birch, grass, and mugwort pollen concentrations and intradiurnal patterns at two different urban sites in Berlin, Germany |
| Q35777120 | Bronchial asthma: is personalized therapy on the horizon? |
| Q35777138 | Bronchitis and asthma in the setting of vitamin D deficiency |
| Q38539744 | Cellular in vitro diagnosis of adverse drug reactions |
| Q26824572 | Change of paradigm: CD8+ T cells as important helper for CD4+ T cells during asthma and autoimmune encephalomyelitis |
| Q127108775 | Characterization of a cohort of storage mite sensitized subjects |
| Q42408154 | Chlorhexidine allergy. |
| Q26823295 | Climate change and air pollution: Effects on pollen allergy and other allergic respiratory diseases |
| Q122664938 | Climate change and allergies |
| Q28264184 | Clinical and diagnostic challenges of metal implant allergy using the example of orthopaedic surgical implants: Part 15 of the Series Molecular Allergology |
| Q26745827 | Clinical spectrum of α-Gal syndrome: from immediate-type to delayed immediate-type reactions to mammalian innards and meat |
| Q35794831 | Cockroach, tick, storage mite and other arthropod allergies: Where do we stand with molecular allergy diagnostics?: Part 15 of the Series Molecular Allergology |
| Q40166274 | Comparison of molecular and extract-based allergy diagnostics with multiplex and singleplex analysis. |
| Q92801771 | Comparison of sublingual immunotherapy and oral immunotherapy in peanut allergy |
| Q28078253 | Coping with cross-reactive carbohydrate determinants in allergy diagnosis |
| Q126799127 | Correction to: Consumer protection and risk assessment: sensitising substances in consumer products |
| Q41974319 | Correspondence to the "Guideline for acute therapy and management of anaphylaxis". |
| Q38952384 | Cost-effectiveness of grass pollen SCIT compared with SLIT and symptomatic treatment |
| Q42365536 | Course of respiratory allergy by treatment strategy based on German routine data |
| Q125481117 | Crowd-sourced symptom data in pollen allergy: testing a novel study approach for assessing the efficacy of food supplements |
| Q49186926 | Current concepts in eosinophilic esophagitis |
| Q49226106 | Current state of follow-up care for patients with Hymenoptera venom anaphylaxis in southwest Germany: Major impact of early information |
| Q36688452 | Current status of allergy prevalence in Germany: Position paper of the Environmental Medicine Commission of the Robert Koch Institute |
| Q127870729 | Development of subcutaneous allergen immunotherapy (part 2): preventive aspects and innovations |
| Q130140742 | Diagnostic gap due to missing patch test allergens—status quo and possible scenarios for mitigation |
| Q33607136 | Diagnostics in Hymenoptera venom allergy: current concepts and developments with special focus on molecular allergy diagnostics |
| Q125470845 | Dogs at home and at the workplace: effects on allergies and mental health |
| Q127966389 | Effectiveness of a portable air filtration device in reducing allergen exposure during household chores |
| Q115228198 | Epithelial barrier hypothesis and the development of allergic and autoimmune diseases |
| Q45937294 | Erratum to: Cockroach, tick, storage mite and other arthropod allergies: Where do we stand with molecular allergy diagnostics? Part 15 of the Series Molecular Allergology. |
| Q129689303 | Evaluation of a modified skin prick test for diagnosis of Hymenoptera venom allergy |
| Q36885641 | Evidence vs. efficacy in allergen-specific immunotherapy: Considerations using the example of tradable products in Germany |
| Q128041823 | Evolution of subcutaneous allergen immunotherapy (part 1): from first developments to mechanism-driven therapy concepts |
| Q56965115 | Food allergies resulting from immunological cross-reactivity with inhalant allergens: Guidelines from the German Society for Allergology and Clinical Immunology (DGAKI), the German Dermatology Society (DDG), the Association of German Allergologists ( |
| Q37693860 | German guideline for the management of adverse reactions to ingested histamine: Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the Germa |
| Q56992605 | German pollen calendar 4.0 – update based on 2011–2016 pollen data |
| Q127930342 | German pollen calendar 4.0: update of the regional pollen calendars 4.0 with measurement data for the period 2011–2016 |
| Q35776986 | Glucoamylase: a current allergen in the baking industry |
| Q38543062 | Guideline contact dermatitis: S1-Guidelines of the German Contact Allergy Group (DKG) of the German Dermatology Society (DDG), the Information Network of Dermatological Clinics (IVDK), the German Society for Allergology and Clinical Immunology (DGAK |
| Q35777144 | Guideline for acute therapy and management of anaphylaxis: S2 Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Association of German Allergologists (AeDA), the Society of Pediatric Allergy and Environmental Medici |
| Q40292371 | Guideline for authors: Allergo Journal International |
| Q35777131 | Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergolo |
| Q35777126 | Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Asso |
| Q128560106 | Guideline: Hereditary angioedema due to C1 inhibitor deficiency |
| Q56965111 | Guidelines on the management of IgE-mediated food allergies: S2k-Guidelines of the German Society for Allergology and Clinical Immunology (DGAKI) in collaboration with the German Medical Association of Allergologists (AeDA), the German Professional A |
| Q104462571 | Healthcare provision for insect venom allergy patients during the COVID-19 pandemic |
| Q42408245 | House dust mites known to be an allergen source for 50 years: Der p 1 still detectable in the original sample |
| Q125471000 | How molecular diagnostics help us to correctly identify pet allergies |
| Q120556409 | How will climate change alter the dynamics of airborne pollen and pollen load of allergenic plants? |
| Q27002411 | Human heart as a shock organ in anaphylaxis |
| Q95276153 | Hypersensitivity reactions to biologics (part I): allergy as an important differential diagnosis in complex immune-derived adverse events |
| Q122859842 | Hypersensitivity reactions to biologics (part II): classifications and current diagnostic and treatment approaches |
| Q34670994 | Hypersensitivity reactions to modern antiplatelet and anticoagulant drugs |
| Q127389976 | IgE-mediated hypersensitivity to chlorhexidine among first-year dental students |
| Q26859542 | Immunodeficiency in adults a practical guide for the allergist |
| Q35776969 | Lichenoid contact reaction to eugenol presenting as oral lichen planus |
| Q92991174 | Long-acting muscarinic antagonists for the treatment of asthma in children-a new kid in town |
| Q28083908 | Mammalian meat allergy: a diagnostic challenge |
| Q35777108 | Marker allergens of weed pollen - basic considerations and diagnostic benefits in the clinical routine: Part 16 of the Series Molecular Allergology |
| Q102327371 | Mast cells and IgE in defense against lethality of venoms: Possible "benefit" of allergy[] |
| Q125408216 | Methods and standards of pollen monitoring—significance of pollen measurements at different altitudes |
| Q41048687 | Microbiota, regulatory T cell subsets, and allergic disorders |
| Q35777051 | Mites and other indoor allergens - from exposure to sensitization and treatment. |
| Q27004195 | Modern diagnosis of celiac disease and relevant differential diagnoses in the case of cereal intolerance |
| Q28088673 | Molecular allergy diagnostics using IgE singleplex determinations: methodological and practical considerations for use in clinical routine: Part 18 of the Series Molecular Allergology |
| Q36688572 | Molecular allergy diagnostics using multiplex assays: methodological and practical considerations for use in research and clinical routine: Part 21 of the Series Molecular Allergology |
| Q35776981 | Molecular sIgE profile in infants and young children with peanut sensitization and eczema |
| Q26861565 | Mould allergens: Where do we stand with molecular allergy diagnostics?: Part 13 of the series Molecular Allergology |
| Q55423435 | NSAID hypersensitivity – recommendations for diagnostic work up and patient management. |
| Q47117802 | New trends in anaphylaxis |
| Q57193201 | Non-celiac gluten/wheat sensitivity (NCGS)-a currently undefined disorder without validated diagnostic criteria and of unknown prevalence: Position statement of the task force on food allergy of the German Society of Allergology and Clinical Immunolo |
| Q28081241 | Novel insights into the role of immune cells in skin and inducible skin-associated lymphoid tissue (iSALT) |
| Q26748993 | Novel strategies for the treatment of asthma |
| Q90468731 | Novel vaccines targeting dendritic cells by coupling allergoids to mannan |
| Q42408181 | Occupational allergy to β-lactam antibiotics |
| Q125906722 | Part I: Insect stings and bites—Beyond the realm of bee and wasp allergies |
| Q55425189 | Perioperative drug reactions - practical recommendations for allergy testing and patient management. |
| Q125420920 | Phenology as a tool to gain more insights into the grass pollen season |
| Q91474160 | Placebo effects in allergen immunotherapy: an experts' opinion |
| Q91474166 | Positive and negative AIT trials: What makes the difference? |
| Q94378889 | Presentations |
| Q125438250 | Prolonging the period of allergenic burden: late-flowering grasses and local peculiarities |
| Q26861547 | Quality of life in the setting of anaphylaxis and food allergy |
| Q42082610 | Reply to the correspondence to the "Guideline for acute therapy and management of anaphylaxis". |
| Q90747724 | Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution? |
| Q38539741 | Rupatadine: efficacy and safety of a non-sedating antihistamine with PAF-antagonist effects |
| Q26744978 | S2k guideline on diagnosis and treatment of atopic dermatitis — short version |
| Q35777045 | S3-Guideline on allergy prevention: 2014 update: Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Society for Pediatric and Adolescent Medicine (DGKJ). |
| Q57193203 | SCIT with a high-dose house dust mite allergoid is well tolerated: safety data from pooled clinical trials and more than 10 years of daily practice analyzed in different subgroups |
| Q128982308 | Safety of a high-dose house dust mite allergoid in pediatric patients |
| Q30313303 | Six years of INSTAND e. V. sIgE proficiency testing: An evaluation of in vitro allergy diagnostics |
| Q38539738 | Sphingosine-1-phosphate as signaling molecule in the skin: Relevance in atopic dermatitis |
| Q28081325 | Spiking with recombinant allergens to improve allergen extracts: benefits and limitations for the use in routine diagnostics: Part 19 of the Series Molecular Allergology |
| Q52643512 | Subtyping of polyposis nasi: phenotypes, endotypes and comorbidities. |
| Q27023029 | Th22 cells in allergic disease |
| Q28074633 | The red meat allergy syndrome in Sweden |
| Q26747223 | Update on the bird-egg syndrome and genuine poultry meat allergy |
| Q123224756 | Vegan diet—alternative protein sources as potential allergy risk |
| Q64970851 | Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases. |
| Q56971253 | Visual analogue scales (VAS): Measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care: Position Paper of the German Society of Allergology (AeDA) and the German Society of A |
| Q53827849 | Vitamin A and D in allergy: from experimental animal models and cellular studies to human disease. |
| Q129159882 | What’s new in the Global Initiative for Asthma 2018 report and beyond |
Search more.